Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Recruiting 11Not yet recruiting 5Completed 3Unknown 1

Sponsor Class

OTHER 5

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Breast Neoplasms 469Neoplasms 327Colorectal Neoplasms 236Carcinoma, Non-Small-Cell Lung 233Lung Neoplasms 200Prostatic Neoplasms 179Carcinoma, Hepatocellular 173Stomach Neoplasms 138Pancreatic Neoplasms 126Leukemia, Myeloid, Acute 114Uterine Cervical Neoplasms 110Rectal Neoplasms 105Multiple Myeloma 93Recurrence 88Squamous Cell Carcinoma of Head and Neck 84Head and Neck Neoplasms 78Neoplasm Metastasis 76Ovarian Neoplasms 75Brain Neoplasms 69Colonic Neoplasms 68Glioblastoma 66Esophageal Neoplasms 66Triple Negative Breast Neoplasms 65Endometrial Neoplasms 58Precursor Cell Lymphoblastic Leukemia-Lymphoma 56Small Cell Lung Carcinoma 54Disease 54Motor Activity 53Hematologic Neoplasms 53Glioma 46

Interventions

nimotuzumab 2surufatinib 1Hematologic Tests 1Gemcitabine 1Blood Specimen Collection 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER × Pancreatic cancer, adult × Clear all
NCT07529626 2026-04-14

MIND-PANC

Shanghai Zhongshan Hospital

Not yet recruiting
320 enrolled
Gastrointestinal

Pancreatic cancer, adult, Anxiety Disorders, Depression, Pancreatic Neoplasms, Disease Progression

NCT07436741 2026-02-27

Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable Pancreatic Cancer

Tianjin Medical University Cancer Institute and Hospital

Phase 3 Not yet recruiting
106 enrolled
Gastrointestinal

Pancreatic cancer, adult

NCT07277452 2025-12-11

NOTABLE-309

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Not yet recruiting
156 enrolled
Gastrointestinal

Pancreatic cancer, adult

NCT06938503 2025-04-22

AG Plus Nimotuzumab Sequential Irreversible Electroporation Ablation for Locally Advanced Pancreatic Cancer

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Not yet recruiting
48 enrolled
Gastrointestinal

Pancreatic cancer, adult

NCT06760741 2025-01-07

PREVENPANC

Hospital Clinic of Barcelona

Not yet recruiting
900 enrolled
Gastrointestinal

Pancreatic cancer, adult, Pancreatic carcinoma, familial, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡